Page last updated: 2024-08-26

phillyrin and Cardiomegaly

phillyrin has been researched along with Cardiomegaly in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Cao, D; Chen, X; Li, X; Liu, Q; Luo, Q; Tang, K; Yang, S; Zhong, B1

Other Studies

1 other study(ies) available for phillyrin and Cardiomegaly

ArticleYear
Phillyrin attenuates norepinephrine-induced cardiac hypertrophy and inflammatory response by suppressing p38/ERK1/2 MAPK and AKT/NF-kappaB pathways.
    European journal of pharmacology, 2022, Jul-15, Volume: 927

    Topics: Animals; Cardiomegaly; Glucosides; MAP Kinase Signaling System; Mice; Mice, Inbred C57BL; NF-kappa B; Norepinephrine; p38 Mitogen-Activated Protein Kinases; Proto-Oncogene Proteins c-akt; Rats

2022